Vectura to advance asthma inhaler after phase 2 studies show ease of use by young children

Vectura to advance asthma inhaler after phase 2 studies show ease of use by young children

Source: 
Fierce Biotech
snippet: 

Vectura unveiled positive results from two phase 2 studies evaluating the ability of young children and toddlers with asthma to use its nebulized inhaler, suggesting that its VR647 budesonide system could reduce delivery times and lower steroid doses compared to current treatments.